2.0
8. Juni 2011
Ehemaliger Mitarbeiter
Newbury, England
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Well respected by customers. Strong history to the company. Has some very interesting drugs in the pipeline, providing the marketing background is done before launch and not after.
Kontras
Constant change in structure meant that there was a regular look over the shoulder to check what is coming. Difficult to plan for the future when the route to the destination kept changing. Amateurish in the approach to what could/should have been big pharmaceutical brands. Thinks is a big pharma company but acts like a small one.